Newsmakers

ImagineAR (OTC: IPNFF) Announces Partnership with Engaged Nation, An Award Winning Leader In Digital Engagement Marketing For Casinos

Engaged Nation Services Many Top Casinos in North America VANCOUVER and ERIE, PA , May 12, 2020 – ImagineAR (IP:CSE) (IPNFF:OTCQB)) an Augmented Reality Company that enables businesses to create their own mobile phone AR campaigns, is pleased […]

Newsmakers

fuboTV (OTC: FUBO) Co-founder & CEO David Gandler To Be Interviewed By Canaccord Genuity Analyst Maria Ripps on Video Webcast for Investors on May 11, 2020

Facebank Group, Inc. d/b/a fuboTV (OTCQB: FUBO) announced today that Co-founder & CEO David Gandler will be featured on a video webcast hosted by Canaccord Genuity analyst Maria Ripps on May 11, 2020. The presentation […]

Newsmakers

Manuscript Describes How CytoDyn’s (OTC: CYDY) Leronlimab Disrupts CCL5/RANTES-CCR5 Pathway, Thereby Restoring Immune Homeostasis, Reducing Plasma Viral Load, Reversing Hyper Immune Activation and Inflammation in Critical COVID-19 Patients

VANCOUVER, Washington, May 06, 2020 (GLOBE NEWSWIRE via COMTEX) — Manuscript Posted Online to Research Square and MedRxiv Pre-print Server CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO […]

Healthcare

Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn (OTC: CYDY) for Drug Product Used in COVID-19 Clinical Trials

SAN DIEGO, May 5, 2020  —- Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing services agreement with CytoDyn Inc., […]

Newsmakers

fuboTV Announces Ticker Symbol Change To (OTC: FUBO)

FaceBank Group, Inc. (d/b/a fuboTV) announced today that the company’s ticker symbol on the OTCQB has changed to “FUBO” from “FBNK” effective tomorrow at market open. The number of shares outstanding of the registrant’s common […]

Healthcare

CytoDyn (OTC: CYDY) Reports Strong Results from eIND COVID-19 Patients Treated with Leronlimab; Majority of Patients Have Demonstrated Remarkable Recoveries

54 eINDs approved by FDA and 49 patients have been treated with leronlimab thus far VANCOUVER, Washington, Apr 30, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab […]

Newsmakers

NexTech AR (OTC: NEXCF) Acquires Work From Home (WFH) Virtual Events Webcasting Live Streaming Software Company Jolokia

The combined companies launching AR first Virtual Conferences NEW YORK and TORONTO, April 30, Apr 30, 2020 — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), a leader in augmented reality for eCommerce […]

Newsmakers

fuboTV (OTC: FBNK) CEO David Gandler Featured by Wedbush Securities Managing Director of Digital Media Equity Research Michael Pachter in Public Company Spotlight

FaceBank Group, Inc. d/b/a fuboTV [OTCQB:FBNK] CEO David Gandler was featured in a discussion led by Michael Pachter, Managing Director of Digital Media Equity Research at Wedbush Securities, to dive deeper into trends around cord-cutting, […]

Newsmakers

ImagineAR (OTC: IPNFF) Signs Five Year $300,000USD Licensing Agreement with SlapItOn to Provide Augmented Reality for Athletes and Celebrities to Engage Fans

Contract Revenue is $300,000USD Plus 5 Year Management Program Revenue Fees VANCOUVER and ERIE, PA, April 29, 2020  – Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) (“ImagineAR” or “Company”) is pleased to announce the signing of a […]

Healthcare

CytoDyn (OTC: CYDY) Announces Vyrologix as Proprietary Name for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients in the United States

Company appoints Interim Chief Financial Officer VANCOUVER, Washington, Apr 27, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for […]

Healthcare

CytoDyn (OTC: CYDY) Submits Completed Biologics License Application (BLA) to the FDA for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients

VANCOUVER, Washington, Apr 27, 2020  — During the FDA’s review period, the Company will dedicate all resources to ensure availability of leronlimab for COVID-19 patients; Cancer programs continue with positive results VANCOUVER, Washington, April 27, 2020 […]

Newsmakers

CytoDyn to Hold Conference Call to Provide Updates on Completion of BLA Filing for HIV, Timeline for Potential Approval of Treatment for COVID-19 Patients, and Two Publications, Including The New England Journal of Medicine

VANCOUVER, Washington, Apr 24, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]